| Advantages | They maintain key disease features, including genetic mutations and protein expression profiles, establishing them as robust platforms for pancreatic cancer research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Pancreas |
| Disease | Pancreatic cancer |
| Organoid Characterization | Pancreatic cancer organoids display high pathological fidelity to tumor tissues, expressing key markers including ANXA1, ANXA10, and ANXA13. |
| Applications | Their capacity to preserve tumor heterogeneity and model the tumor microenvironment (TME) supports in-depth analysis of disease progression and therapeutic response. As physiologically relevant tools, pancreatic cancer organoids are critical for driving precision medicine and enabling the discovery of more effective treatments for this challenging malignancy. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.